The Global GMP Cell Banking Service Market was valued USD 874.01 Million in 2023 and projected to reach USD 2,147.04 Million by 2030, growing at a CAGR of 13.7% during the forecast period of 2023-2030
Richmond, Feb. 05, 2024 (GLOBE NEWSWIRE) — According to a research report “GMP Cell Banking Service Market”, By Cell Type (Mammalian, Microbial, Insect, Yeast, Avian, Stem Cell, Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization) and Region – Global Forecast to 2030.
Global GMP Cell Banking Service Market Report Scope:
|Market size value in 2023
|USD 874.01 Million
|Market size value in 2030
|USD 2,147.04 Million
|Value (USD Million/USD Billion)
|Cell Type, End User and Region
|North America, Europe, Asia Pacific, and RoW
|Sample of Companies Covered
Download the Sample – https://www.marketdigits.com/request/sample/3939
TOC Covers in Depth & Breath on GMP Cell Banking Service Market
170 – Market Data Tables
65 – List of Figures
225 – Pages
The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits.
The GMP (Good Manufacturing Practice) Cell Banking Service Market encompasses a vital segment within the biopharmaceutical industry, providing essential services for the storage and maintenance of master cell banks (MCBs) and working cell banks (WCBs) compliant with rigorous regulatory standards. This market is characterized by the increasing demand for advanced biologics and cell-based therapies, driving the need for reliable cell banking solutions to ensure product quality, safety, and consistency. Key players in the market offer a range of services including cell line characterization, cell line storage, and distribution, catering to the diverse needs of biopharmaceutical companies, contract research organizations (CROs), and academic institutions engaged in drug development and bioprocessing. Factors such as stringent regulatory requirements, technological advancements in cell culture techniques, and growing investments in biopharmaceutical R&D contribute to the steady growth and evolution of the GMP Cell Banking Service Market.
Major vendors in the global GMP Cell Banking Service Market:
- WuXi AppTec
- Charles River Laboratories
- Eurofins Scientific
- Merck KGaA
- SGS Life Sciences Ltd.
- Goodwin Biotechnology
- Paragon Bioservices
- Bio Reliance
- Thermo Fisher
- BSL Bioservice
Request for Discount @ https://www.marketdigits.com/request/discount/3939
Growing Biopharmaceutical Sector
The growing biopharmaceutical sector serves as a significant driver for the expansion of the GMP Cell Banking Service Market due to its reliance on advanced biologics and cell-based therapies. With an increasing focus on personalized medicine and novel treatment modalities, biopharmaceutical companies are continually developing innovative therapeutics that require precise cell line development and banking services to ensure product quality, safety, and efficacy. Moreover, the rising prevalence of chronic diseases, coupled with the aging population, further amplifies the demand for biopharmaceuticals, thereby fueling the need for reliable GMP-compliant cell banking solutions. As biopharmaceutical companies strive to accelerate drug development pipelines and bring new therapies to market, the importance of robust cell banking services becomes paramount, driving sustained growth in the market.
- Rising Complexity of Cell-Based Therapies
- Growing Demand for Gene and Cell Therapies
- The growing trend towards personalized medicine
- Advancement in Drug Delivery Technologies
- Surge in demand for Personalized Medicine and Gene Therapy
The Rising Demand For GMP Compliant Services
The rising demand for GMP (Good Manufacturing Practice) compliant services is a notable trend propelling the growth of the GMP Cell Banking Service Market. This trend is primarily driven by stringent regulatory requirements governing the biopharmaceutical industry, necessitating adherence to rigorous quality standards throughout the drug development and manufacturing process. As biopharmaceutical companies increasingly prioritize regulatory compliance to ensure product safety and efficacy, the demand for GMP-compliant cell banking services surges. These services play a crucial role in supporting biopharmaceutical firms in achieving regulatory approval by providing comprehensive solutions for the storage, characterization, and distribution of master cell banks (MCBs) and working cell banks (WCBs) in compliance with GMP guidelines. Consequently, the market witnesses sustained growth as companies seek reliable partners offering expertise in GMP-compliant cell banking services to navigate the complex regulatory landscape effectively.
Inquire Before Buying: https://www.marketdigits.com/request/enquiry-before-buying/3939
North America dominates the market for GMP Cell Banking Service Market.
North America has emerged as a dominant force in the GMP (Good Manufacturing Practice) Cell Banking Service Market primarily due to several factors. Firstly, the region boasts advanced healthcare infrastructure, including state-of-the-art research facilities and regulatory frameworks that prioritize safety and quality standards, thereby fostering a conducive environment for cell banking services. Secondly, a robust biotechnology and pharmaceutical industry presence in North America has propelled the demand for GMP-compliant cell banking services to support drug development, clinical trials, and bio manufacturing processes. Additionally, North America benefits from a strong ecosystem of academic institutions, biotech startups, and established companies, facilitating collaboration and innovation in cell therapy and regenerative medicine. Combined, these factors position North America at the forefront of the GMP Cell Banking Service Market, driving its dominance in the global landscape.
Mammalian Segments is anticipated to hold the Largest Market Share during the Forecast Period
Based on the Cell Type segment categorized into Mammalian, Microbial, Insect, Yeast, Avian, Stem Cell, Others. Hospitals has a major share in the GMP Cell Banking Service Market. The mammalian cell type segment holds the major share. This dominance can be attributed to several factors. Mammalian cells, including human cells, are widely utilized in biopharmaceutical production, particularly for the development of cell-based therapies, monoclonal antibodies, and recombinant proteins. These cells offer significant advantages such as the ability to produce complex proteins with post-translational modifications essential for therapeutic efficacy. Moreover, mammalian cell lines are extensively employed in preclinical and clinical studies, necessitating reliable and compliant cell banking services to ensure product safety, consistency, and regulatory compliance. Additionally, the increasing focus on personalized medicine and the development of advanced therapies further fuel the demand for mammalian cell banking services, reinforcing its position as the leading segment in the GMP Cell Banking Service Market.
Segmentations Analysis of GMP Cell Banking Service Market: –
- By Cell Type
- Stem Cell
- By End User
- Biopharmaceutical Companies
- Contract Manufacturing Organization
- By Region
- North America
- Latin America
- Asia Pacific
- Middle East & Africa
Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights @ https://www.marketdigits.com/checkout/3939?lic=s
Browse Similar Reports:
Biobanking Market 2030 By Type, Distribution Channel, End-user and Region – Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Core Banking Solution Market 2030 By Type, Distribution Channel, End-user and Region – Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Banking-As-A-Service Market 2030 By Type, Distribution Channel, End-user and Region – Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
In Vitro Fertilization Banking Services Market 2030 By Type, Distribution Channel, End-user and Region – Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. SingaporeOutlook.com takes no editorial responsibility for the same.